Benjamin Sherer, MD


  1. Tan WP, Sherer BA, Hoeksema J. Ecthyma gangrenosum of the scrotum: a case report. Front Med. 2016 Mar; 10(1):101-3.
  2. Sherer BA, Levine LA. Contemporary Review of Treatment Options for Peyronie's Disease. Urology. 2016 Sep; 95:16-24.
  3. Tan WP, Sherer BA, Khare N. Unfriendly Filter: An Unusual Cause of Hydronephrosis and Hematuria. Urology. 2016 Jan; 87:e9-e10.
  4. Sherer BA, Coogan CL. Reply to Letter to the Editor: The Current State of Urologic Malpractice in Spain. Urology. 2015 Oct; 86(4):846-7.
  5. Farrell MR, Sherer BA, Levine LA. Visual Internal Urethrotomy With Intralesional Mitomycin C and Short-term Clean Intermittent Catheterization for the Management of Recurrent Urethral Strictures and Bladder Neck Contractures. Urology. 2015 Jun; 85(6):1494-9.
  6. Farrell MR, Sherer BA, Levine LA. Reply: To PMID 26099892. Urology. 2015 Jun; 85(6):1499-500.
  7. Sherer BA, Godlewski KF, Levine LA. Pharmacologic therapy for Peyronie's disease: what should we prescribe? Expert Opin Pharmacother. 2015 Jun; 16(9):1299-311.
  8. Sherer BA, Coogan CL. The Current State of Medical Malpractice in Urology. Urology. 2015 Jul; 86(1):2-9.
  9. Sherer BA, Warrior K, Levine LA. 2013-2014 updates in Peyronie's disease management. Curr Urol Rep. 2014 Dec; 15(12):459.
  10. Sherer BA, Levine LA. Current management of erectile dysfunction in prostate cancer survivors. Curr Opin Urol. 2014 Jul; 24(4):401-6.
  11. Ju AW, Wang H, Oermann EK, Sherer BA, Uhm S, Chen VJ, Pendharkar AV, Hanscom HN, Kim JS, Lei S, Suy S, Lynch JH, Dritschilo A, Collins SP. Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer. Radiat Oncol. 2013; 8:30.
  12. Oermann EK, Suy S, Hanscom HN, Kim JS, Lei S, Yu X, Zhang G, Ennis B, Rohan JP, Piel N, Sherer BA, Borum D, Chen VJ, Batipps GP, Constantinople NL, Dejter SW, Bandi G, Pahira J, McGeagh KG, Adams-Campbell L, Jha R, Dawson NA, Collins BT, Dritschilo A, Lynch JH, Collins SP. Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low- to intermediate-risk prostate cancer. J Hematol Oncol. 2011; 4:12.
  13. Oermann EK, Slack RS, Hanscom HN, Lei S, Suy S, Park HU, Kim JS, Sherer BA, Collins BT, Satinsky AN, Harter KW, Batipps GP, Constantinople NL, Dejter SW, Maxted WC, Regan JB, Pahira JJ, McGeagh KG, Jha RC, Dawson NA, Dritschilo A, Lynch JH, Collins SP. A pilot study of intensity modulated radiation therapy with hypofractionated stereotactic body radiation therapy (SBRT) boost in the treatment of intermediate- to high-risk prostate cancer. Technol Cancer Res Treat. 2010 Oct; 9(5):453-62.
  14. Liu Y, Sherer BA, Redetzke RA, Gerdes AM. Regulation of arteriolar density in adult myocardium during low thyroid conditions. Vascul Pharmacol. 2010 Mar-Apr; 52(3-4):146-50.
  15. Liu Y, Wang D, Redetzke RA, Sherer BA, Gerdes AM. Thyroid hormone analog 3,5-diiodothyropropionic acid promotes healthy vasculature in the adult myocardium independent of thyroid effects on cardiac function. Am J Physiol Heart Circ Physiol. 2009 May; 296(5):H1551-7.